Fischer, Kady
Linder, Olivier L.
Erne, Sophie A.
Stark, Anselm W.
Obrist, Sarah J.
Bernhard, Benedikt
Guensch, Dominik P.
Huber, Adrian T.
Kwong, Raymond Y.
Gräni, Christoph http://orcid.org/0000-0001-6029-0597
Funding for this research was provided by:
University of Bern
Article History
Received: 13 June 2021
Revised: 23 August 2021
Accepted: 14 October 2021
First Online: 21 December 2021
Declarations
:
: The scientific guarantor of this publication is Christoph Gräni (Christoph.graeni@insel.ch).
: Raymond Y. Kwong receives research support from NIH awards 1UH2 TR000901, 1RO1DK083424-01, and 1U01HL117006, Alnylam Pharmaceuticals, and the Society for the Cardiovascular Magnetic Resonance. Christoph Gräni receives funding support from the Swiss National Science Foundation. All other authors have nothing to declare.
: No complex statistical methods were necessary for this paper.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: Portions of this cohort from one of the sites (Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA) have been previously published for the aims of prognostication of imaging and clinical markers. The current manuscript now includes patients from a larger combined registry which is now dual-center. Additionally, there is no overlap with the aims of this submission and previous publications. (ExternalRef removed, ExternalRef removed, ExternalRef removed, ExternalRef removed).
: • Retrospective• Multi-center• Observational study